Category Archives: Events

Latest From Events

BIO World Congress Update: Call for Proposals Deadline Extended!

BIO World Congress

The 2016 BIO World Congress on Industrial Biotechnology is taking place next April 17-20, 2016 in sunny San Diego, CA. BIO has officially extended the Call for Proposals Deadline to November 20, 2016. So, there is still time to submit an abstract for a panel session, speaker submission, or GreenTech Investor Session! Proposed presentations can cover a range of topics, including: Renewable Chemicals Biobased Products Enzyme development Algae for fuels and bioproducts Specialty Chemicals Synthetic Read More >

Environmental & Industrial, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , ,

Haves and Have Nots in Biotech Venture Capital


Recent data from the BIO Industry Analysis team tells a story of “haves and have-nots” in US biopharma venture capital. Three key findings were discussed Wednesday at the 14th Annual BIO Investor Forum. The first finding from the recent study is that funding of therapeutic companies is strong for late rounds (Series B and above), but weak for Series A. Although total levels of venture funding have been climbing recently, the majority of the increase is from late rounds. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

BIO Investor Forum Closes with Record Attendance


The 14th Annual BIO Investor Forum wrapped up in San Francisco yesterday, having exceeded all previous attendance and participation records. The energy and buzz around #BIF15 is another sign of the continued strength and resilience of the biotech industry. This year’s forum brought together over 900 registered attendees and 175 presenting companies, facilitating 1700 meetings between investors and senior management for emerging and established biotechnology companies. Scott Whitaker, President of the BIO International Convention and Read More >

Events  |  Leave a comment  |  Email This Post

Fireside Chat: “Everything we knew in science 10 years ago is wrong.”


The speed of scientific innovation these days is comparable to the PC innovation era of the 1980s, according to Robert Nelsen of ARCH Venture Partners at today’s BIO Investor Forum fireside chat. This is not to say that he feels investing in biopharma is a short term game. Robert urged the audience to “keep their faith” in good science and the “good ideas will percolate up” to yield innovative breakthroughs. Having played a significant role Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Stretching Your Dollar: Methods and Tools for Increasing the Productivity of Clinical Trials


Recent Tufts data show clinical trials typically take nearly twice as long to complete enrollment as predicted at launch and 48% of trial sites miss enrollment targets.  Delays in trials shrink the returns from patent exclusivity and increase R&D costs.  New methods such as adaptive and batch trial designs, as well as explosive growth in digital tools, such as Apple’s ResearchKit, have transformed the trial design choices available.  These innovations, and others, provide new levers Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,